Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas

E. Radaelli, A. Arnold, A. Papanikolaou, R. A. Garcia-Fernandez, S. Mattiello, E. Scanziani, Robert Cardiff

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Prolactin-secreting pituitary adenomas are common spontaneous lesions in aging FVB females. Prolactin-secreting pituitary proliferations play a significant role in mouse mammary tumorigenesis generally producing adenosquamous carcinomas. Since genetically engineered FVB mice are frequently used to study mammary tumor biology, we have examined a cohort of 64 aging wild-type FVB/N females to establish the prevalence and the nature of spontaneous mammary and pituitary tumors. Tissues from mammary and pituitary glands were studied by histopathology and immunohistochemistry. Of the 64 examined mice, 20 had pituitary tumors and 20 had mammary tumors. Mammary and pituitary tumors were associated in 17 mice. All pituitary tumors were prolactin-positive by immunohistochemistry and classified as prolactinomas. Fourteen mammary tumors, including 12 cases with and 2 without concurrent prolactinomas, were adenocarcinomas with different combinations of epithelial growth patterns. Five mice with prolactinomas had mammary tumors characterized by the epithelial-mesenchymal transition (EMT) phenotype. Estrogen receptor alpha (ERa)-positivity was observed for 14 of the 18 mammary tumors tested, including both adenocarcinomas with nuclear immunoreactivity and EMT-phenotype tumors with both nuclear and cytoplasmic immunoreactivity. No immunoreactivity for the progesterone receptor was observed. This study confirms that spontaneous prolactinomas and mammary tumors are both common and significantly associated lesions in FVB mice. Parity and age represented risk factors for the development of these tumors. Compared with previous reports, prolactinoma-associated mammary tumors displayed a broader morphologic spectrum, including cases with the EMT phenotype. The elevated number of prolactinoma-associated and ERa-positive mammary tumors opens intriguing possibilities concerning the role of ERα cytoplasmic localization during EMT tumorigenesis.

Original languageEnglish (US)
Pages (from-to)736-745
Number of pages10
JournalVeterinary Pathology
Volume46
Issue number4
DOIs
StatePublished - Jul 1 2009

Fingerprint

Prolactinoma
mammary neoplasms (animal)
Breast Neoplasms
Phenotype
phenotype
mice
Epithelial-Mesenchymal Transition
neoplasms
Pituitary Neoplasms
prolactin
breasts
adenocarcinoma
carcinogenesis
Estrogen Receptor alpha
immunohistochemistry
Prolactin
Carcinogenesis
Adenocarcinoma
Immunohistochemistry
pituitary gland

Keywords

  • Epithelial to mesenchymal transition
  • Estrogen receptor alpha
  • FVB/N mice
  • Immunohistochemistry
  • Mammary carcinogenesis
  • Parity status
  • Prolactin

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Radaelli, E., Arnold, A., Papanikolaou, A., Garcia-Fernandez, R. A., Mattiello, S., Scanziani, E., & Cardiff, R. (2009). Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas. Veterinary Pathology, 46(4), 736-745. https://doi.org/10.1354/vp.08-VP-0280-R-FL

Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas. / Radaelli, E.; Arnold, A.; Papanikolaou, A.; Garcia-Fernandez, R. A.; Mattiello, S.; Scanziani, E.; Cardiff, Robert.

In: Veterinary Pathology, Vol. 46, No. 4, 01.07.2009, p. 736-745.

Research output: Contribution to journalArticle

Radaelli, E, Arnold, A, Papanikolaou, A, Garcia-Fernandez, RA, Mattiello, S, Scanziani, E & Cardiff, R 2009, 'Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas', Veterinary Pathology, vol. 46, no. 4, pp. 736-745. https://doi.org/10.1354/vp.08-VP-0280-R-FL
Radaelli E, Arnold A, Papanikolaou A, Garcia-Fernandez RA, Mattiello S, Scanziani E et al. Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas. Veterinary Pathology. 2009 Jul 1;46(4):736-745. https://doi.org/10.1354/vp.08-VP-0280-R-FL
Radaelli, E. ; Arnold, A. ; Papanikolaou, A. ; Garcia-Fernandez, R. A. ; Mattiello, S. ; Scanziani, E. ; Cardiff, Robert. / Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas. In: Veterinary Pathology. 2009 ; Vol. 46, No. 4. pp. 736-745.
@article{e088e4cbbaaf44579ab7cd4e0c4f9d65,
title = "Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas",
abstract = "Prolactin-secreting pituitary adenomas are common spontaneous lesions in aging FVB females. Prolactin-secreting pituitary proliferations play a significant role in mouse mammary tumorigenesis generally producing adenosquamous carcinomas. Since genetically engineered FVB mice are frequently used to study mammary tumor biology, we have examined a cohort of 64 aging wild-type FVB/N females to establish the prevalence and the nature of spontaneous mammary and pituitary tumors. Tissues from mammary and pituitary glands were studied by histopathology and immunohistochemistry. Of the 64 examined mice, 20 had pituitary tumors and 20 had mammary tumors. Mammary and pituitary tumors were associated in 17 mice. All pituitary tumors were prolactin-positive by immunohistochemistry and classified as prolactinomas. Fourteen mammary tumors, including 12 cases with and 2 without concurrent prolactinomas, were adenocarcinomas with different combinations of epithelial growth patterns. Five mice with prolactinomas had mammary tumors characterized by the epithelial-mesenchymal transition (EMT) phenotype. Estrogen receptor alpha (ERa)-positivity was observed for 14 of the 18 mammary tumors tested, including both adenocarcinomas with nuclear immunoreactivity and EMT-phenotype tumors with both nuclear and cytoplasmic immunoreactivity. No immunoreactivity for the progesterone receptor was observed. This study confirms that spontaneous prolactinomas and mammary tumors are both common and significantly associated lesions in FVB mice. Parity and age represented risk factors for the development of these tumors. Compared with previous reports, prolactinoma-associated mammary tumors displayed a broader morphologic spectrum, including cases with the EMT phenotype. The elevated number of prolactinoma-associated and ERa-positive mammary tumors opens intriguing possibilities concerning the role of ERα cytoplasmic localization during EMT tumorigenesis.",
keywords = "Epithelial to mesenchymal transition, Estrogen receptor alpha, FVB/N mice, Immunohistochemistry, Mammary carcinogenesis, Parity status, Prolactin",
author = "E. Radaelli and A. Arnold and A. Papanikolaou and Garcia-Fernandez, {R. A.} and S. Mattiello and E. Scanziani and Robert Cardiff",
year = "2009",
month = "7",
day = "1",
doi = "10.1354/vp.08-VP-0280-R-FL",
language = "English (US)",
volume = "46",
pages = "736--745",
journal = "Veterinary Pathology",
issn = "0300-9858",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas

AU - Radaelli, E.

AU - Arnold, A.

AU - Papanikolaou, A.

AU - Garcia-Fernandez, R. A.

AU - Mattiello, S.

AU - Scanziani, E.

AU - Cardiff, Robert

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Prolactin-secreting pituitary adenomas are common spontaneous lesions in aging FVB females. Prolactin-secreting pituitary proliferations play a significant role in mouse mammary tumorigenesis generally producing adenosquamous carcinomas. Since genetically engineered FVB mice are frequently used to study mammary tumor biology, we have examined a cohort of 64 aging wild-type FVB/N females to establish the prevalence and the nature of spontaneous mammary and pituitary tumors. Tissues from mammary and pituitary glands were studied by histopathology and immunohistochemistry. Of the 64 examined mice, 20 had pituitary tumors and 20 had mammary tumors. Mammary and pituitary tumors were associated in 17 mice. All pituitary tumors were prolactin-positive by immunohistochemistry and classified as prolactinomas. Fourteen mammary tumors, including 12 cases with and 2 without concurrent prolactinomas, were adenocarcinomas with different combinations of epithelial growth patterns. Five mice with prolactinomas had mammary tumors characterized by the epithelial-mesenchymal transition (EMT) phenotype. Estrogen receptor alpha (ERa)-positivity was observed for 14 of the 18 mammary tumors tested, including both adenocarcinomas with nuclear immunoreactivity and EMT-phenotype tumors with both nuclear and cytoplasmic immunoreactivity. No immunoreactivity for the progesterone receptor was observed. This study confirms that spontaneous prolactinomas and mammary tumors are both common and significantly associated lesions in FVB mice. Parity and age represented risk factors for the development of these tumors. Compared with previous reports, prolactinoma-associated mammary tumors displayed a broader morphologic spectrum, including cases with the EMT phenotype. The elevated number of prolactinoma-associated and ERa-positive mammary tumors opens intriguing possibilities concerning the role of ERα cytoplasmic localization during EMT tumorigenesis.

AB - Prolactin-secreting pituitary adenomas are common spontaneous lesions in aging FVB females. Prolactin-secreting pituitary proliferations play a significant role in mouse mammary tumorigenesis generally producing adenosquamous carcinomas. Since genetically engineered FVB mice are frequently used to study mammary tumor biology, we have examined a cohort of 64 aging wild-type FVB/N females to establish the prevalence and the nature of spontaneous mammary and pituitary tumors. Tissues from mammary and pituitary glands were studied by histopathology and immunohistochemistry. Of the 64 examined mice, 20 had pituitary tumors and 20 had mammary tumors. Mammary and pituitary tumors were associated in 17 mice. All pituitary tumors were prolactin-positive by immunohistochemistry and classified as prolactinomas. Fourteen mammary tumors, including 12 cases with and 2 without concurrent prolactinomas, were adenocarcinomas with different combinations of epithelial growth patterns. Five mice with prolactinomas had mammary tumors characterized by the epithelial-mesenchymal transition (EMT) phenotype. Estrogen receptor alpha (ERa)-positivity was observed for 14 of the 18 mammary tumors tested, including both adenocarcinomas with nuclear immunoreactivity and EMT-phenotype tumors with both nuclear and cytoplasmic immunoreactivity. No immunoreactivity for the progesterone receptor was observed. This study confirms that spontaneous prolactinomas and mammary tumors are both common and significantly associated lesions in FVB mice. Parity and age represented risk factors for the development of these tumors. Compared with previous reports, prolactinoma-associated mammary tumors displayed a broader morphologic spectrum, including cases with the EMT phenotype. The elevated number of prolactinoma-associated and ERa-positive mammary tumors opens intriguing possibilities concerning the role of ERα cytoplasmic localization during EMT tumorigenesis.

KW - Epithelial to mesenchymal transition

KW - Estrogen receptor alpha

KW - FVB/N mice

KW - Immunohistochemistry

KW - Mammary carcinogenesis

KW - Parity status

KW - Prolactin

UR - http://www.scopus.com/inward/record.url?scp=67650889517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650889517&partnerID=8YFLogxK

U2 - 10.1354/vp.08-VP-0280-R-FL

DO - 10.1354/vp.08-VP-0280-R-FL

M3 - Article

C2 - 19276050

AN - SCOPUS:67650889517

VL - 46

SP - 736

EP - 745

JO - Veterinary Pathology

JF - Veterinary Pathology

SN - 0300-9858

IS - 4

ER -